javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.347264063491152.6303
Domestic EquitiesLupin Limited7.31062783991631.3256
Domestic EquitiesDr. Reddy's Laboratories Limited6.71664449746580.0244
Domestic EquitiesCipla Limited6.15683795054531.6871
Domestic EquitiesDivi's Laboratories Limited5.7960750754500.5277
Domestic EquitiesApollo Hospitals Enterprise Limited5.1961548795448.7222
Domestic EquitiesMankind Pharma Limited3.93711431195339.9947
Domestic EquitiesMedPlus Health Services Limited3.67513545229317.3689
Domestic EquitiesSai Life Sciences Limited3.43302555745296.4664
Domestic EquitiesAjanta Pharma Limited3.2095946323277.1685
Domestic EquitiesVijaya Diagnostic Centre Limited3.20872117639277.0931
Domestic EquitiesMax Healthcare Institute Limited2.97062658082256.5315
Domestic EquitiesThyrocare Technologies Limited2.56024366909221.0966
Domestic EquitiesIPCA Laboratories Limited2.40911364742208.0413
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.3373913226201.8412
Domestic EquitiesAurobindo Pharma Limited2.31681402630200.0711
Domestic EquitiesAbbott India Limited2.311874339199.6374
Domestic EquitiesGland Pharma Limited2.0858800549180.1235
Domestic EquitiesAlkem Laboratories Limited2.0607323678177.9582
Domestic EquitiesDr. Lal Path Labs Limited1.89531018224163.6693
Domestic EquitiesNarayana Hrudayalaya Limited1.8070823911156.0487
Domestic EquitiesSyngene International Limited1.79223501497154.7662
Domestic EquitiesPfizer Limited1.6947318249146.3468
Domestic EquitiesEmcure Pharmaceuticals Limited1.4658746337126.5788
Domestic EquitiesSuraksha Diagnostic Limited1.28953896349111.3577
Domestic EquitiesFortis Healthcare Limited1.18681103889102.4906
Domestic EquitiesSanofi Consumer Healthcare India Limited1.135321365998.0374
Domestic EquitiesAnthem Biosciences Limited0.9315105850380.4409
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.9203151526479.4756
Domestic EquitiesSanofi India Limited0.825823027271.3175
Domestic EquitiesBiocon Limited0.7293146937462.9847
Domestic EquitiesAstraZeneca Pharma India Limited0.62546256854.0056
Domestic EquitiesIndoco Remedies Limited0.4455183492438.4710
Domestic EquitiesConcord Biotech Limited0.136011173811.7459
Total 97.9191 8456.0464
Cash & Cash Equivalents and Net AssetsTriparty Repo2.1587 186.4217
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0010 0.0897
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0789 -6.8106
Total 2.0809 179.7008
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.